Azenta (NASDAQ:AZTA) PT Raised to $65.00 at Stephens

Azenta (NASDAQ:AZTAGet Rating) had its target price hoisted by Stephens from $60.00 to $65.00 in a research report issued to clients and investors on Thursday, The Fly reports. Stephens’ price objective would indicate a potential upside of 12.89% from the stock’s previous close.

A number of other research analysts have also recently commented on the stock. Needham & Company LLC increased their target price on shares of Azenta from $74.00 to $78.00 and gave the stock a “buy” rating in a report on Tuesday. TheStreet downgraded Azenta from a “c-” rating to a “d+” rating in a research note on Thursday, September 1st. KeyCorp lowered their price objective on Azenta from $90.00 to $70.00 and set an “overweight” rating for the company in a research note on Monday, October 24th. Finally, Evercore ISI lowered their price objective on Azenta to $68.00 in a research note on Monday, August 15th. Four investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $72.60.

Azenta Trading Down 3.3 %

AZTA stock opened at $57.58 on Thursday. The stock has a market capitalization of $4.32 billion, a P/E ratio of 2.03 and a beta of 1.52. Azenta has a 12 month low of $37.61 and a 12 month high of $121.24. The firm has a 50-day moving average price of $45.71 and a 200-day moving average price of $59.99.

Institutional Trading of Azenta

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vigilant Capital Management LLC acquired a new stake in Azenta during the 2nd quarter valued at approximately $25,000. Glassman Wealth Services acquired a new stake in Azenta during the 2nd quarter valued at approximately $25,000. Quadrant Capital Group LLC acquired a new stake in Azenta during the 2nd quarter valued at approximately $26,000. Castle Wealth Management LLC acquired a new stake in Azenta during the 2nd quarter valued at approximately $34,000. Finally, Assetmark Inc. acquired a new stake in Azenta during the 2nd quarter valued at approximately $39,000. Institutional investors and hedge funds own 97.43% of the company’s stock.

About Azenta

(Get Rating)

Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.

Featured Stories

The Fly logo

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.